If coadministration cannot be avoided, monitor for adverse reactions related to the concomitantly administered BCRP substrates, including rosuvastatin [see Clinical Pharmacology (12.3) ].
Source: FDA drug label - tedizolid phosphate
Brand names: Sivextro
1 interaction on record
If coadministration cannot be avoided, monitor for adverse reactions related to the concomitantly administered BCRP substrates, including rosuvastatin [see Clinical Pharmacology (12.3) ].
Source: FDA drug label - tedizolid phosphate